Circulating tumor cells (CTCs) are tumor cells that shed from the primary tumor and
intravasate into the peripheral blood circulation system responsible for metastasis. Sensitive …

In most cases, once nanoparticles (NPs) enter the blood, their surface is covered by
biological molecules, especially proteins, forming a so-called protein corona (PC). As a …

For systemically delivered nanoparticles to reach target tissues, they must first circulate long
enough to reach the target and extravasate there. A challenge is that the particles end up …

In vivo liposomes, like other types of nanoparticles, acquire a totally new 'biological
identity'due to the formation of a biomolecular coating known as the protein corona that …

The unique physicochemical properties of two-dimensional (2D) graphene oxide (GO) could
greatly benefit the biomedical field; however, recent research demonstrated that GO could …

Although a wide variety of nanoparticles (NPs) have been engineered for use as disease
markers or drug delivery agents, the number of nanomedicines in clinical use has hitherto …

The response of living systems to nanoparticles is thought to depend on the protein corona,
which forms shortly after exposure to physiological fluids and which is linked to a wide array …

In the past few years, concerns of protein-gold nanoparticles (AuNP) interaction have been
continuously growing in numerous potential biomedical applications. Despite the advances …

For several decades, surface grafted polyethylene glycol (PEG) has been a go-to strategy for
preserving the synthetic identity of liposomes in physiological milieu and preventing …

Protein corona of nanoparticles (NPs), which forms when these particles come in to contact
with protein-containing fluids, is considered as an overlooked factor in nanomedicine …